• Mashup Score: 3

    In his first president’s message to American Society of Nuclear Cardiology (ASNC), 2023 President Mouaz H. Al-Mallah, MD, MSc, FASNC, called for the cardiac imaging subspecialty to up its game with new technology [1].   “Nuclear cardiology imaging remains at the center stage in the era of multimodality testing,” Al-Mallah said in his first President’s Message to ASNC members this past week….

    Tweet Tweets with this article
    • American Society of Nuclear Cardiology (ASNC) 2023 President Mouaz Al-Mallah said the subspecialty needs to up its game with new technology. #ASNC #CVnuc #cardiotwitter @almallahmo #CVimaging #radiology https://t.co/1m6UPg5lqr

  • Mashup Score: 1

    The biggest news from the American Society of Nuclear Cardiology (ASNC) 2022 meeting was positive late-breaking data on the phase 3 Aurora trial for the flurpiridaz (F-18) positron emission tomography (PET) radiotracer agent. Numerous nuclear cardiology experts have predicted the radiopharmaceutical might significantly accelerate PET adoption in nuclear cardiology with its 106 minute half life…

    Tweet Tweets with this article
    • Flurpiridaz data shows promise to expand and enhance cardiac PET #cardiacPET #Nuclearcardiology #ASNC #ASNC22 #ASNC2022 #Flurpiridaz https://t.co/bW0Fbb8gFP

  • Mashup Score: 0

    September 7, 2022 — The American Society of Nuclear Cardiology (ASNC) and three partner societies have come together to answer cardiac imagers’ questions about SPECT/CT and PET/CT imaging with attenuation correction, localization of radiotracer uptake and coronary artery calcium scoring (CACS). In a new multisociety guideline published today in the Journal of Nuclear Cardiology, the organizations…

    Tweet Tweets with this article
    • @DAICeditor @MyASNC #ASNC and three partner societies have come together to answer #cardiac imagers’ questions about #SPECT_CT and #PET_CT imaging with attenuation correction, localization of radiotracer uptake and #coronaryartery #calciumscoring (#CACS): https://t.co/sktW5l3Mdc

  • Mashup Score: 1

    August 10, 2022 — On July 27, ASNC joined a coalition of more than 100 medical societies urging Congress to pass legislation that provides at least a 4.5 percent conversion factor adjustment and waives a statutory PAYGO requirement that will otherwise result in a 4 percent sequestration next year on top of the existing 2 percent sequestration. The letter specifies that any legislation should…

    Tweet Tweets with this article
    • @DAICeditor @MyASNC #ASNC joined a #coalition of more than 100 #medical societies urging #Congress to pass #legislation that provides at least a 4.5% conversion factor adjustment and waives a statutory #PAYGO requirement: https://t.co/gugPC9h1lA

  • Mashup Score: 0

    July 19, 2022 — On July 7, the Centers for Medicare & Medicaid Services (CMS) released the 2023 Medicare Physician Fee Schedule (PFS) proposed rule. In the days ahead the American Society of Nuclear Cardiology’s (ASNC) advocacy team will analyze the proposed rule and report to you on specifics that may impact your practice as well as any actions ASNC will take. CMS also posted a notice about the…

    Tweet Tweets with this article
    • @DAICeditor @MyASNC On July 7 #CMS released the 2023 Medicare #PFS proposed rule; the #ASNC advocacy team will analyze the proposed rule and report to you on specifics that may impact your practice as well as any actions ASNC will take: https://t.co/6cUxyLrye9

  • Mashup Score: 2

    The American Medical Association (AMA) Board of Delegates approved a policy calling on payers to reimburse for the drug regadenoson (Lexiscan) and not to employ payment policies that push for cardiologists to change the drug they use for pharmacologic stress for one that is considered less safe. The policy was adopted at the AMA 2022 meeting last week. Many cardiologists prefer to use…

    Tweet Tweets with this article
    • AMA supports reimbursement for pharmacologic stress agent regadenoson #CVimaging #ASNC #AMA #AMA175 #AMAmtg #radiology #pharmacuticals @MyASNC @AmerMedicalAssn https://t.co/iYODeguhNQ

  • Mashup Score: 1

    September 22, 2021 — Test selection should be a shared decision between patient and physician rather than directed by insurers’ test substitution policies, according to a statement published online in the Journal of the American College of Cardiology.[1] The statement summarizes the proceedings of a recent summit convened by the American Society of Nuclear Cardiology (ASNC), where six leading…

    Tweet Tweets with this article
    • Cardiovascular Imaging Organizations Denounce Test Substitution by Insurance Companies https://t.co/i2s8oOZJvz #cardiotwitter #cardiology #CVimaging #ASNC #ASE #SCCT #SCMR #SNMMI